Flash Finance

Biogen Pharmachem Industries Ltd531752Corporate

Other Financial Services Latest results: Jun 2026 14 quarters of data
₹0.28
MCap ₹27 Cr
Biogen Pharmachem Industries Ltd — Stock analysis & AI research Biogen Pharmachem Industries Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹0 Cr
Sales · Jun 2026
₹0 Cr
Operating Profit · Jun 2026
+210.7% YoY
49.9%
OPM % · Jun 2026
₹0 Cr
Net Profit · Jun 2026
-83.5% YoY
₹0.00
EPS · Jun 2026
-100.0% YoY

📝 Biogen Pharmachem Industries Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Biogen Pharmachem Industries Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), and down 23.6% sequentially over the March 2026 quarter.

Net profit fell 83.5% year-on-year to ₹0 crore, from ₹1 crore.

Operating profit stood at ₹0 crore — an operating margin (OPM) of 49.9%.

Full year and trailing twelve months

For the full year FY26, Biogen Pharmachem Industries Ltd posted revenue of ₹1 crore, a decline of 11.1% over FY25, with a net profit of ₹1 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹2 crore with a net loss of ₹0 crore.

Valuation snapshot

At the current price of ₹0.28, 531752 has a market capitalisation of ₹27 crore.

Within the Other Financial Services industry, it is the 25th-largest of the 94 companies we track by market value.

Shareholding pattern

As of Jun 2026, public shareholders 100.00% of Biogen Pharmachem Industries Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹27 Cr
Current Price ?
₹0.3
P/E ?
N/A
Industry P/E ?
25.40
P/B ?
0.28
P/S ?
17.51
P/FCF ?
17.44
Enterprise Value ?
₹27 Cr
EV/EBITDA ?
-399.13
PEG ?
N/A
Earnings Yield ?
-0.3%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹2 Cr
OPM ?
-4.4%
Profit after tax (TTM) ?
₹-0 Cr
EPS (TTM) ?
₹-0.00
ROCE ?
1.0%
ROE ?
-0.2%
ROA ?
-0.2%
Growth
Sales — latest qtr ?
₹0 Cr
PAT — latest qtr ?
₹0 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
-83.5%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
10%
Profit growth (3y) ?
85%
Profit growth (5y) ?
20%
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
N/A
Change in promoter holding ?
N/A
Pledged percentage ?
N/A
Market
Return 3 months ?
-15.2%
Return 6 months ?
-39.5%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales -01001-000100110 — -23.6%
Operating Profit -00-0-01-0-0-11-0-00-00 +210.7% +161.5%
Other Income 001000-1002-000— — —
Interest 0000000000000— — —
Depreciation 0000000000000— — —
Profit Before Tax -00101-0-1-011-00-00 -83.5% +161.5%
Net Profit -00101-0-1-011-00-00 -83.5% +161.5%
EPS 0.000.010.010.000.010.00-0.010.000.020.010.000.000.000.00 -100.0% —
OPM % 2000.0% 54.7% — — 94.9% 177.8% — — 87.4% — — 85.2% -62.1% 49.9% — +180.4%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1 Cr ₹1 Cr ₹2 Cr -11.1%
Operating Profit ₹0 Cr ₹-0 Cr ₹-0 Cr -476.9%
OPM % 10.32% -43.75% -4.39% -523.9%
NPM % -23.02% 84.82% -10.78% +468.5%
Other Income ₹-0 Cr ₹1 Cr ₹-0 Cr +442.9%
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr —
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹0 Cr ₹-0 Cr ₹-0 Cr -476.9%
PBT ₹-0 Cr ₹1 Cr ₹-0 Cr +427.6%
Tax — — — —
Net Profit ₹-0 Cr ₹1 Cr ₹-0 Cr +427.6%
EPS ₹0.01 ₹0.01 ₹0.00 +0.0%
Material Cost — — — —
Employee Cost — — ₹0 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 65.2665.2665.2690.26 +38.3%
Reserves -10.67-8.7426.678.83 -66.9%
Borrowings 0.000.000.000.00 —
Other Liabilities 0.240.300.090.31 +244.4%
Total Liabilities 54.8356.8292.0299.40 +8.0%
Fixed Assets 0.000.000.000.00 —
CWIP 0.000.000.000.00 —
Investments 8.855.4423.8432.78 +37.5%
Other Assets 45.9851.3868.1866.62 -2.3%
Total Assets 54.8356.8292.0299.40 +8.0%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 1.701.94-1.081.57 +245.4%
Cash from Investing Activity -1.66-2.06-32.62-9.56 +70.7%
Cash from Financing Activity 0.000.0035.706.30 -82.4%
Net Cash Flow 0.05-0.112.00-1.69 -184.5%
Free Cash Flow 1.701.94-1.081.57 +245.4%
CFO/OP -378%101%372%164% -55.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days —0.000.000.00 —
Cash Conversion Cycle —0.000.000.00 —
Working Capital Days —-35.27170.33-19.96 -111.7%
ROCE % -0.37%3.47%-0.39%1.01% +359.0%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Public 100.00%100.00%99.99%100.00% +0.0%
No. of Shareholders 2,93,3272,89,9872,89,1552,93,626 +1.5%

⚖️ Peer comparison

Industry: Other Financial Services · top 25 of 94 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 504346 RRP Semiconductor ₹15.00 11,623 — -7 -8 106.3% 113.8% -121.6% -191.6% -100.0% 88.7%
2 542866 Colab Platforms ₹15.54 2,571 65.8 159 5 1.1% 3.1% 129.3% 65.3% 3.4% 12.9%
3 ALGOQUANT Algoquant Fintech ₹70.78 1,990 43.7 258 45 26.8% 17.6% — — 44.2% 312.0%
4 507912 LKP Finance ₹172.17 1,322 — — — — — -87.8% -97.0% — —
5 GYFTR Gyftr ₹164.51 1,264 73.1 534 17 -5.5% 3.2% — — 1306.7% -22.4%
6 526071 Stellant Securities ₹27.09 503 n/m 0 0 47.1% 47.1% — 200.0% -25.0% 400.0%
7 540175 Regency Fincorp ₹14.74 364 7.2 43 17 74.3% 40.3% 72.7% 170.4% 107.9% 122.4%
8 540199 Corporate Merchant ₹16.63 326 80.3 — 1 — — — 13.0% — -188.9%
9 542332 Hi-Klass Trading ₹5.62 263 2.3 15 7 66.7% 48.7% 598.5% -252.4% 6017.2% 3360.2%
10 540097 Gamco ₹64.46 260 — 360 -30 -2.9% -8.2% 385.5% -771.4% 106.4% 116.2%
11 535916 Alacrity Securities ₹83.80 242 40.1 451 10 2.8% 2.2% -28.0% -44.1% 57.4% 92.4%
12 503635 Shree Salasar ₹13.89 223 0.5 120 22 29.7% 18.0% 152.8% 652.7% 38.9% 129.3%
13 531550 Jhaveri Credits ₹363.95 216 — 99 -5 -7.7% -4.6% 30.4% -113.4% 73.6% -224.3%
14 501151 Kartik Investments ₹748.10 158 3.6 6 5 98.1% 86.9% 29250.0% 25600.0% — 200.0%
15 539113 Paul Merchants ₹506.25 151 — 2,061 -10 -0.3% -0.5% -37.8% 321.0% -2.5% -96.9%
16 531310 Available Finance ₹236.85 142 1.6 0 147 58.1% 97549.3% — 2.9% — 108.7%
17 540455 Escorp Asset ₹71.44 127 12.5 7 6 88.4% 88.0% -82.7% -81.7% 684.2% 460.2%
18 511260 Iconik Sports ₹16.64 118 13.0 46 4 12.1% 9.5% 258.0% 66.2% 44.4% -64.0%
19 512345 Lexora Global ₹20.37 115 — 0 -0 -214.7% -178.7% — -4.2% — -150.8%
20 507864 Pioneer Investcorp ₹84.05 108 7.2 38 14 35.6% 37.5% 29.0% 101.4% -56.3% -45.3%
21 509945 Thacker ₹1,097.00 94 6.3 6 19 88.8% 325.1% -7.7% -8.6% -2.2% -3.6%
22 531688 Prithvi Exchange ₹318.30 85 117.5 3,983 2 0.1% 0.1% 5.9% -67.3% 29.4% -34.4%
23 512018 Tomorrow Technologies ₹9.60 85 — 0 -0 -178.7% -146.6% -92.5% 100.0% -95.6% -305.0%
24 508905 Nexome Capital ₹49.58 81 4.9 34 11 37.4% 31.1% 22.0% 816.2% -81.8% -2.0%
25 531752 Biogen Pharmachem ₹1.40 27 — 2 -0 -4.4% -10.8% -11.1% 427.6% — -83.5%
❓ Frequently asked questions
What was Biogen Pharmachem Industries Ltd's revenue in Q1 FY27?
Biogen Pharmachem Industries Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), and down 23.6% sequentially over the March 2026 quarter.
What was Biogen Pharmachem Industries Ltd's net profit in Q1 FY27?
Net profit fell 83.5% year-on-year to ₹0 crore, from ₹1 crore.
What is 531752's market capitalisation and P/E ratio?
At the current price of ₹0.28, 531752 has a market capitalisation of ₹27 crore.
Who owns Biogen Pharmachem Industries Ltd? (shareholding pattern)
As of Jun 2026, public shareholders 100.00% of Biogen Pharmachem Industries Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI